Contributor #K-6641
Anonymous submitter. Method-section completeness over time.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
98.93%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042497 | IGF-1 LR3 | Homopeptide | HOMO-2607-P5131 | Janoshik | 2026-Q3 | 98.89 | 6.25 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042140 | PT-141 (Bremelanotide) | JEEP | JEEP-2601-K8195 | Janoshik | 2026-Q2 | 98.28 | 3.89 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-041995 | Thymosin α1 | AMB | AMB-2511-B5683 | PeptideMeter | 2026-Q2 | 98.86 | 4.00 | 104.5 | Buyer-sourced | 0 | PASS |
| AX-2026-041234 | Retatrutide | WWB | WWB-2510-H1662 | PeptideMeter | 2026-Q1 | 99.50 | 4.46 | 99.2 | Buyer-sourced | 0 | PASS |
| AX-2026-043561 | Liraglutide | SIG | SIG-2508-6459 | Janoshik | 2026-Q1 | 98.14 | 5.50 | 101.8 | Buyer-sourced | 0 | PASS |
| AX-2026-042983 | Semaglutide | MKM | MKM-2508-R3717 | Kestrel | 2026-Q1 | 98.90 | 5.42 | 91.5 | Buyer-sourced | 0 | PASS |
| AX-2025-019149 | NAD+ | GSP | GSP-2503-B3620 | Janoshik | 2025-Q3 | 99.83 | 9.91 | 92.2 | Buyer-sourced | 0 | PASS |
| AX-2025-019583 | Tirzepatide | TFC | TFC-2508-G1453 | Janoshik | 2025-Q3 | 99.05 | 3.64 | 105.9 | Buyer-sourced | 0 | PASS |
| AX-2025-018664 | Tirzepatide | QSC | QSC-2410-R5814 | Nordanalyt | 2025-Q1 | 99.31 | 4.88 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004163 | Tirzepatide | WWB | WWB-2403-J3152 | Janoshik | 2024-Q3 | 98.96 | 4.01 | — | Buyer-sourced | 0 | PASS |